Okyo Pharma Limited, an ophthalmology-focused bio-pharmaceutical company, announced that it filed an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) for the development of OK-101 to treat dry eye disease...
Novel innovations are now actively hitting the market with an expectation to alter the course of drug manufacturing. In this article, we have listed the top trends in the RNA therapeutic industry:
Merck, known as MSD outside the United States and Canada, and Imago BioSciences, Inc. (Imago) announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Imago for $36.00 per share in...
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Procardia XL extended-release tablets, 30 mg, 60 mg and 90 mg, of Pfizer Inc...
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, announced new data from a large aortic dissection artificial intelligence real-world study that supports the use of its artificial intelligence technology for...
Strides Pharma Science Ltd on Friday said its Singapore-based arm has received approval from the US health regulator for generic potassium chloride oral solution, used to treat or prevent low amounts of potassium in the blood. The approval granted...
Microvi, a transformative biology company based in the San Francisco Bay Area, announced that it has been awarded over $1.1 million in funding from the National Institute of Health (NIH) to scale-up its newly developed technology to eliminate ....
In this article, we have focused on recent innovations in the biopharmaceutical sector that has the potential to change pharmaceutical drug development.
With more than 70 million diabetic patients, India is known as the diabetes capital of the world. On top of that, the country is on its way to reach 200 million pre-diabetics as well. Driven by the increasing number of diabetes patients in the cou...
Aurobindo Pharma Ltd on said it has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing facility at Pydibhimavaram in Andhra Pradesh. The company's Unit XI at Pydibhimavaram is an API...
, CDSCO.jpg)
